Pipmed Medical
Indocyanine green (ICG) is a near-infrared fluorescent dye. Protein-bound ICG can be excited by external light with a wavelength range of 750 ~ 810 nm, emitting near-infrared light at approximately 840nm. Its half-life in blood is about 3 ~ 5 minutes. After entering the blood and binding to protein, it is absorbed by liver cells, enters the intestine through the biliary tract, and is eventually excreted with feces.
This indocyanine green injection is the first in China to pass double consistency evaluations, offering high purity, low impurity content, and optimized storage conditions. It provides stable and reliable diagnosis and treatment options for the medical community.
Standard Improvement
Advanced control limits for known impurities promote the improvement of industrial standards for indocyanine green substances.
Patent Protection
Strongly protected structure, synthesis processes, and biological activities with 4 Chinese and American invention patents, establishing solid industrial barriers.
Ambient Storage & Transportation
Stored at room temperature without the need for a cold chain, improving transportation convenience and global accessibility of medical resources.



Indications: Detection of choroidal neovascularization, macular lesions, intraocular tumors, and retinal vascular lesions; Intraoperative staining of capsule and internal limiting membrane.
Advantages: Provides clear choroidal vascular images for accurate diagnosis. In cataract and retinal surgery, ICG staining helps physicians identify and treat membranes precisely, reducing complications.
Indications: Evaluation of liver reserve function; liver tumor image development, liver segment identification, and bile leakage observation.
Advantages: Optimal method for rapid and safe liver function evaluation. Fluorescence characteristics help physicians identify liver structures clearly, improving surgical safety.
Indications: Accurate localization of tumors, imaging of the lymphatic system, and assessment of blood supply.
Advantages: Intuitive target judgment through fluorescence signals enhances visibility during complex operations.




Portfolio includes research, development, production, and sales of high-end medical devices (fluorescence imaging series), contrast agents (ICG, targeted series), and core components (CMOS camera modules, endoscopes). These products are utilized in more than 500 large hospitals.


Focusing on core technologies such as molecular fluorescence, Raman spectroscopy, AI, and computer-aided drug design (CADD). As a specialized "little giant" enterprise, the manufacturer holds 131 core invention patents and 7 US patents.

